[Nipiopharmacology from the ophthalmological point of view].
D000109:Acetylcholine / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D001285:Atropine / Q000009:adverse effects; D003348:Cortisone / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D004837:Epinephrine / Q000009:adverse effects; D005123:Eye / Q000187:drug effects; D005128:Eye Diseases / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D009883:Ophthalmic Solutions; D010372:Pediatrics; D010656:Phenylephrine / Q000009:adverse effects; D010862:Pilocarpine / Q000009:adverse effects; D012835:Silver Nitrate / Q000009:adverse effects; D013449:Sulfonamides / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D009883:Ophthalmic Solutions; D013449:Sulfonamides; D010862:Pilocarpine; D010656:Phenylephrine; D001285:Atropine; D012835:Silver Nitrate; D000109:Acetylcholine; D003348:Cortisone; D004837:Epinephrine
Nipiofarmacologia dal punto di vista oculistico.